LINC02257, an Enhancer RNA of Prognostic Value in Colon Adenocarcinoma, Correlates With Multi-Omics Immunotherapy-Related Analysis in 33 Cancers
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LINC02257, an Enhancer RNA of Prognostic Value in Colon Adenocarcinoma, Correlates With Multi-Omics Immunotherapy-Related Analysis in 33 Cancers
Authors
Keywords
-
Journal
Frontiers in Molecular Biosciences
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-04-30
DOI
10.3389/fmolb.2021.646786
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nuclear long non-coding RNAs as epigenetic regulators in cancer
- (2021) Hiroaki Tachiwana et al. CURRENT MEDICINAL CHEMISTRY
- Regulation of anti-tumorigenic pathways by the combinatory treatment of calcitriol and TGF-β in PC-3 and DU145 cells
- (2021) Mitzi García-Olivares et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- circRNA_100859 functions as an oncogene in colon cancer by sponging the miR-217-HIF-1α pathway
- (2020) Peng Zhou et al. Aging-US
- Role of non-coding RNAs as novel biomarkers for detection of colorectal cancer progression through interaction with the cell signaling pathways
- (2020) Mohadeseh Esmaeili et al. GENE
- Prognostic Nomograms for Predicting Overall Survival and Cancer-Specific Survival of Patients With Early Onset Colon Adenocarcinoma
- (2020) Huimin Jin et al. Frontiers in Oncology
- AP001056.1, A Prognosis-Related Enhancer RNA in Squamous Cell Carcinoma of the Head and Neck
- (2019) Xiaolian Gu et al. Cancers
- Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities
- (2019) Suhas Vasaikar et al. CELL
- Analysis of the long non-coding RNA LINC01614 in non-small cell lung cancer
- (2019) Yan Sun et al. MEDICINE
- Molecular Pathology of Colorectal Cancer
- (2019) Shuko Harada et al. ADVANCES IN ANATOMIC PATHOLOGY
- Landscape of immune microenvironment in hepatocellular carcinoma and its additional impact on histological and molecular classification
- (2018) Yutaka Kurebayashi et al. HEPATOLOGY
- PD-L1 Expression, Tumor Mutational Burden, and Response to Immunotherapy in Patients with MET exon 14 Altered Lung Cancers
- (2018) J K Sabari et al. ANNALS OF ONCOLOGY
- Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
- (2018) T A Chan et al. ANNALS OF ONCOLOGY
- Immunomodulation of the Tumor Microenvironment: Turn Foe Into Friend
- (2018) Hanne Locy et al. Frontiers in Immunology
- Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
- (2017) Aaron M. Goodman et al. MOLECULAR CANCER THERAPEUTICS
- Microsatellite Instability
- (2017) Liisa Chang et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Classification and characterization of microsatellite instability across 18 cancer types
- (2016) Ronald J Hause et al. NATURE MEDICINE
- Enhancers as non-coding RNA transcription units: recent insights and future perspectives
- (2016) Wenbo Li et al. NATURE REVIEWS GENETICS
- Enhancer-associated RNAs as therapeutic targets
- (2015) Nicolas Léveillé et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- DUSP10 regulates intestinal epithelial cell growth and colorectal tumorigenesis
- (2015) C W Png et al. ONCOGENE
- Tissue-based map of the human proteome
- (2015) M. Uhlen et al. SCIENCE
- Network dynamics in the tumor microenvironment
- (2015) Hamid Bolouri SEMINARS IN CANCER BIOLOGY
- Systematic pan-cancer analysis of tumour purity
- (2015) Dvir Aran et al. Nature Communications
- Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation
- (2014) C.-L. Hsieh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer immunotherapy
- (2013) Lauren Gravitz NATURE
- Inferring tumour purity and stromal and immune cell admixture from expression data
- (2013) Kosuke Yoshihara et al. Nature Communications
- PI3K and Akt as molecular targets for cancer therapy: current clinical outcomes
- (2012) Ipsita Pal et al. ACTA PHARMACOLOGICA SINICA
- eRNAs Are Required for p53-Dependent Enhancer Activity and Gene Transcription
- (2012) Carlos A. Melo et al. MOLECULAR CELL
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- Clinical Relevance of Microsatellite Instability in Colorectal Cancer
- (2010) Albert de la Chapelle et al. JOURNAL OF CLINICAL ONCOLOGY
- Widespread transcription at neuronal activity-regulated enhancers
- (2010) Tae-Kyung Kim et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now